ClinConnect ClinConnect Logo
Search / Trial NCT05348733

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Launched by BAYER · Apr 26, 2022

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

The FINE-REAL study is looking at how well the medication finerenone works for people with chronic kidney disease (CKD) and type 2 diabetes (T2D) when prescribed by their doctors in everyday medical care. CKD can happen when diabetes damages the kidneys over time, making it harder for them to filter waste from the blood. Finerenone helps protect the kidneys by blocking certain proteins that can cause damage. This study will gather information about patients who have recently started taking finerenone, including why they started, how long they’ve been on it, and if they experienced any side effects, especially high potassium levels, which can be a concern.

To join the study, participants need to be at least 18 years old and have a doctor's diagnosis of CKD linked to T2D. They should have started taking finerenone within the last two months. During the study, which lasts for 12 months, participants will provide information during routine check-ups and may give blood and urine samples to help researchers learn more about the medication's effects over time. This study is important because it aims to better understand how finerenone is used in real-life settings, helping improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult participants of all genders (≥18 years old)
  • Diagnosis of CKD associated with T2D based on assessment by physician.
  • Treatment according to local marketing authorization, finerenone 20 or 10 mg.Treatment should have been started up to 8 weeks before or after the ICF is signed.
  • Decision to initiate treatment with finerenone must be made before ICF is signed.
  • Signed informed consent
  • Exclusion Criteria:
  • Participation in an investigational trial at any time during the course of this study
  • Contra-indications according to the local label.

About Bayer

Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.

Locations

Salt Lake City, Utah, United States

West Palm Beach, Florida, United States

Shreveport, Louisiana, United States

Reno, Nevada, United States

Chicago, Illinois, United States

Salt Lake City, Utah, United States

Augusta, Georgia, United States

Greensboro, North Carolina, United States

Charlotte, North Carolina, United States

Harrisburg, Arkansas, United States

Granada Hills, California, United States

Multiple Locations, , Korea, Republic Of

Port Charlotte, Florida, United States

El Paso, Texas, United States

Suwanee, Georgia, United States

Multiple Locations, , Germany

Multiple Locations, , Greece

Multiple Locations, , Taiwan

Los Angeles, California, United States

Alexandria, Virginia, United States

Multiple Locations, , Russian Federation

Multiple Locations, , China

Multiple Locations, , France

Multiple Locations, , Italy

Multiple Locations, , Saudi Arabia

Multiple Locations, , Belgium

Multiple Locations, , Canada

Multiple Locations, , Mexico

Multiple Locations, , Spain

Fall River, Massachusetts, United States

Multiple Locations, , Argentina

Multiple Locations, , Denmark

Multiple Locations, , Netherlands

Multiple Locations, , Thailand

Webster, Texas, United States

Multiple Locations, , Switzerland

Honolulu, Hawaii, United States

Los Angeles, California, United States

Multiple Locations, , Colombia

Chicago, Illinois, United States

Reno, Nevada, United States

Grand Rapids, Michigan, United States

Multiple Locations, , Brazil

Multiple Locations, , Luxembourg

Multiple Locations, , Portugal

Multiple Locations, , Slovenia

Alpharetta, Georgia, United States

Multiple Locations, , Singapore

Huntsville, Alabama, United States

Phoenix, Arizona, United States

Glendale, California, United States

West Covina, California, United States

Orlando, Florida, United States

Alpharetta, Georgia, United States

Brunswick, Georgia, United States

Stockbridge, Georgia, United States

Chicago, Illinois, United States

Hinsdale, Illinois, United States

Slidell, Louisiana, United States

Baltimore, Maryland, United States

Jackson, Mississippi, United States

Tupelo, Mississippi, United States

Edison, New Jersey, United States

Flint, Texas, United States

Houston, Texas, United States

Houston, Texas, United States

Mcallen, Texas, United States

Plano, Texas, United States

Tacoma, Washington, United States

San Francisco, California, United States

Terre Haute, Indiana, United States

Iowa City, Iowa, United States

Memphis, Tennessee, United States

Port Charlotte, Florida, United States

Winston Salem, North Carolina, United States

Multiple Locations, , Chile

Port Charlotte, Florida, United States

Minneapolis, Minnesota, United States

Honolulu, Hawaii, United States

Providence, Rhode Island, United States

Patients applied

ME

1 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials